Centre d'Esclerosi Múltiple de Catalunya, CEM-Cat, Unitat de Neuroimmunologia Clínica, Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain.
Clin Immunol. 2012 Jan;142(1):2-8. doi: 10.1016/j.clim.2011.03.004. Epub 2011 Mar 12.
Multiple sclerosis (MS) is a chronic disorder of the central nervous system characterized by autoimmune inflammation, demyelination, and axonal damage. MS etiology remains unknown, but disease phenotype is most likely the result of an interaction between complex genetic factors and environmental influences. The better understanding of the mechanisms involved in the immunopathogenesis of MS has led to the development of promising new therapeutic strategies for the disease. This review will discuss the key pathogenic steps implicated in the disease and the role of the main cellular populations that drive the immune responses in MS.
多发性硬化症(MS)是一种中枢神经系统的慢性疾病,其特征为自身免疫炎症、脱髓鞘和轴索损伤。MS 的病因仍然未知,但疾病表型很可能是复杂遗传因素与环境影响相互作用的结果。对 MS 免疫发病机制中涉及的机制的更好理解,导致了针对该疾病的有前途的新治疗策略的发展。本综述将讨论疾病中涉及的关键发病步骤,以及驱动 MS 中免疫反应的主要细胞群体的作用。